Diabetes
From the Journals
South Asian ancestry associated with twice the risk of heart disease
Findings confirm previous reports identifying South Asian ancestry as a risk enhancer for atherosclerotic cardiovascular disease.
News
New drug, finerenone, approved for slowing kidney disease in diabetes
Finerenone (Kerendia) is the first agent approved from a novel class, the nonsteroidal mineralocorticoid receptor antagonists. But its role in...
From the Journals
Pandemic upped telemedicine use 100-fold in type 2 diabetes
Latest News
FDA rejects teplizumab for type 1 diabetes delay
The decision follows narrow endorsement by an advisory panel.
Conference Coverage
What’s best for diabetes after metformin? GRADE outdated at outset
The GRADE trial compared four different agents as add-ons to metformin for type 2 diabetes, but the study is already outdated, said one...
Conference Coverage
Screen pregnant women for OSA, given known risks
Conference Coverage
‘Praise Diabetes’: Support programs in Black churches yield lasting A1c changes
Statistically significant reductions in A1c and diabetes distress were seen in the Praise Diabetes Project, a 33-month randomized trial, an...
Conference Coverage
AMPLITUDE-O: Efpeglenatide benefits in high-risk diabetes
In older patients with long-time type 2 diabetes and CVD or kidney disease, the investigational GLP-1 agonist efpeglenatide was safe and lowered...
Conference Coverage
Semaglutide 2.4 mg ‘likely to usher in a new era’ in obesity treatment
Clinical experience with this drug will grow rapidly over the next few years, one expert predicts, and new combination drugs are near, so...
Conference Coverage
'Full throttle': 'Diabetes Garage' workshops boost Mexican American men's self-management
Infusing diabetes education with concepts and lingo from car culture is a promising approach to improving self-management behaviors, and might...
Conference Coverage
Nocturnal hypoglycemia halved with insulin degludec vs. glargine
Researchers pitted degludec against glargine U100 in the toughest patients with type 1 diabetes, those who had severe nocturnal hypoglycemia.